Pharmafile Logo
Pharmafocus logo
Advanced Search
Pfizer logo

Pfizer to double patient assistance allowance in the US

November 9, 2015
Sales and Marketing Drug pricing, Pfizer

Pfizer says it will double the allowable income level for its RxPathways patient assistance program in the US with immediate …

News
gsk_hq

GSK asthma drug Nucala gets FDA approval

November 6, 2015
GSK, Nucala, asthma, eosinophils, mepolizumab

GlaxoSmithKline has received approval from the FDA for Nucala as an add-on maintenance treatment of patients with severe asthma aged …

News
boehringers_current_board

Boehringer announces board changes, chairman’s retirement

November 6, 2015
Medical Communications, Sales and Marketing

Boehringer Ingelheim has announced that Professor Andreas Barner will retire as chairman of the Board of Managing Directors on 30 …

Appointment

UK doctors embracing technology, but not for their patients, survey reveals

November 6, 2015
Medical Communications, Research and Development

A global online survey of doctors released by market research agency Cello Health Insight has indicated that although UK doctors …

News
dollar-544956_1280

Top 5 pharma companies’ Q3 results

November 6, 2015
Medical Communications, Sales and Marketing financial results, revenue, sales

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …

Feature
astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015
Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

News
Sanofi logo

Sanofi buys in new diabetes drug

November 6, 2015
Medical Communications, Research and Development, Sales and Marketing Lexicon Pharma, SGLT2, SGLT2 inhibitors, Sanofi, sotagliflozin

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …

News
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …

News
nsclc_merck_pfizer

Merck and Pfizer begin new Phase III avelumab trial in lung cancer

November 5, 2015
Medical Communications, Research and Development Merck, Pfizer, avelumab, lung cancer, non-small cell lung cancer

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …

News
Ikervis

New treatments to boost dry eye drug market – if approved

November 5, 2015
Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast

The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …

News
eye

Featured market report: Summary of dry eye syndrome

November 5, 2015
dry eye disease, dry eye syndrome, lifitegrast

This report provides the current prevalent population for dry eye syndrome across seven major markets.It includes data for the USA, …

Feature
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015
Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …

News
OECD logo

OECD report warns of high spend and slow growth for pharma industry

November 5, 2015
Manufacturing and Production, Sales and Marketing OECD, pharmaceutical spending

The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …

News
President Obama

Obama government launches drug price crackdown

November 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access

President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …

News

NHS England reinstates treatments to Cancer Drugs Fund

November 4, 2015
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NHS England

Five treatments in seven indications have been reinstated to Cancer Drugs Fund, as a result of negotiations between pharma companies …

News
Novo Nordisk building

Novo Nordisk invests in new insulin-filling facility

November 4, 2015
Manufacturing and Production Denmark, Novo Nordisk, manufacturing, production

Novo Nordisk is investing 2.1 billion Danish Kroner (about £200m) in a new facility in Hillerød, Denmark, which will produce diabetes …

News
lradvanyi_2

Merck appoints Laszlo Radvanyi as head of global immuno-oncology research

November 4, 2015
Research and Development Laszlo Radvanyi, Merck

Dr Laszlo Radvanyi has joined Merck as senior vice president and head of research in immuno-oncology.  The Merck Group says …

Appointment
GSK logo

GSK plots return to growth with launch of 20 new drugs by 2020

November 4, 2015
Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline

GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …

News
researchers examining test tube

Drugs later in development ‘winning the race to market’

November 4, 2015
Research and Development R&D, drug approval, drug development, market exclusivity

Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …

News
Andrew Witty GSK

Pfizer approached GSK for takeover before Allergan

November 4, 2015
Research and Development, Sales and Marketing Allergan, GSK, Pfizer, financial results, product pipeline

Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026